Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended on March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eyantra Ventures (formerly Punit Commercials) reported audited FY25 results with standalone revenue from operations nearly doubling to ₹2,759.27 lakhs (vs ₹1,405.78 lakhs in FY24, +96% YoY). Standalone net profit surged to ₹166.39 lakhs (vs ₹74.45 lakhs, +123% YoY), lifting EPS to ₹8.98 from ₹4.46. On a consolidated basis, FY25 revenue grew to ₹3,270.29 lakhs but net profit fell to ₹75.07 lakhs (vs ₹106.49 lakhs) dragged by a ₹38.84 lakh share of loss from associate Neuro and Spine Associates. Q4 FY25 standalone profit dropped sharply to ₹5.06 lakhs and the company posted a consolidated Q4 loss of ₹61.52 lakhs. Both standalone and consolidated operating cash flows were negative (-₹35.07 and -₹113.05 lakhs), with growth funded mainly by a ₹15 crore preferential issue in January 2025.
Strong top-line and standalone earnings growth is positive, but the consolidated profit decline, Q4 standalone profit drop, and negative operating cash flows are concerns for shareholders. The auditor issued an unmodified opinion, providing some comfort on reporting quality.